Venturi Wealth Management LLC Sells 358 Shares of Waters Corporation $WAT

Venturi Wealth Management LLC decreased its position in Waters Corporation (NYSE:WAT) by 13.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,262 shares of the medical instruments supplier’s stock after selling 358 shares during the period. Venturi Wealth Management LLC’s holdings in Waters were worth $790,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Olde Wealth Management LLC bought a new position in shares of Waters in the 1st quarter valued at about $25,000. Zions Bancorporation National Association UT bought a new position in Waters in the first quarter valued at approximately $28,000. IFP Advisors Inc boosted its stake in Waters by 118.9% in the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock valued at $30,000 after acquiring an additional 44 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in Waters during the 1st quarter worth $41,000. Finally, CX Institutional bought a new stake in shares of Waters during the 1st quarter valued at $75,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Price Performance

Shares of NYSE WAT opened at $327.96 on Thursday. The firm has a market cap of $19.52 billion, a P/E ratio of 29.57, a price-to-earnings-growth ratio of 2.97 and a beta of 1.04. The business’s 50 day moving average is $298.31 and its 200-day moving average is $324.73. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. Waters Corporation has a 1-year low of $275.05 and a 1-year high of $423.56.

Waters (NYSE:WAT) last issued its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 EPS for the quarter, beating analysts’ consensus estimates of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The firm had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. During the same period in the prior year, the firm posted $2.63 EPS. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Equities research analysts predict that Waters Corporation will post 12.86 earnings per share for the current year.

Analyst Upgrades and Downgrades

WAT has been the subject of a number of analyst reports. Jefferies Financial Group set a $385.00 price objective on Waters and gave the stock a “buy” rating in a research note on Monday, August 4th. Wells Fargo & Company decreased their target price on Waters from $330.00 to $315.00 and set an “equal weight” rating for the company in a research note on Tuesday, August 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Waters in a research report on Wednesday. Robert W. Baird decreased their price objective on Waters from $374.00 to $352.00 and set an “outperform” rating for the company in a research report on Wednesday, July 16th. Finally, Wall Street Zen cut Waters from a “buy” rating to a “hold” rating in a research note on Saturday, July 26th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $381.63.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.